Tokyo, April 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061126) titled 'An Assessment of the Risk of Cervical Cancer and Precancerous Lesions in Women with Negative Cytology and Positive Human Papillomavirus in Cervical Cancer Screening' on April 2.
Study Type:
Observational
Primary Sponsor:
Institute - Kagoshima University Hospital
Condition:
Condition - Women with a negative cytology (NILM) and positive high-risk HPV in cervical cancer screening
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To assess the risk of cervical dysplasia in women who are cytologically negative (NILM) but positive for high-risk HPV in cervical cancer screening.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 30
years-old
=
Gender - Female
Key inclusion criteria - Women aged 30 to 65 who undergo cervical cancer screening in Kagoshima City and who have agreed to participate in this study. Excluded are women who are pregnant or who have been receiving treatment for cervical cancer or precancerous lesions during the past year.
Key exclusion criteria - Other than the above
Target Size - 30000
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 06 Month 26 Day
Date of IRB - 2025 Year 06 Month 26 Day
Anticipated trial start date - 2025 Year 06 Month 26 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069943
Disclaimer: Curated by HT Syndication.
